Related Experiment Video
Updated: May 13, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in
Lin Wang1, Pei-Feng Li, Ming Geng
1Department of Pathology, General Hospital of Jinan Military Command, Jinan, Shandong Province, China. gm2227@sina.com
Background:
The determination of sensitive chemotherapy drugs for gastric cancer (GC) is one of the greatest challenges of adjuvant therapy. Here we evaluated the chemosensitivity of GC to anticancer drugs and the telomerase reverse transcriptase (hTERT) mRNA expression, and investigated the relationship of them.
Methods:
The GC cells which were collected from 68 patients with primary GC were primary cultured. The chemosensitivity of GC cells to anticancer drugs was evaluated successfully using the MTT assay for 60 cases of GC cells, and the hTERT mRNA expression was examined in 60 cases of GC tissues and corresponding normal gastric mucosa and 6 cases of chronic superficial gastritis mucosa by in situ hybridization.
Results:
Taxol, cisplatin and 5-fluorouracil were in general more effective than adriamycin and mitomycin for GC cells, and the chemosensitivity to anticancer drugs was associated with tumor histological types and a worse tumor grade. Compared to normal gastric mucosa tissues, hTERT mRNA expression was significantly increased in GC (P<0.05), which was related with a worse differentiation and drug-resistance to 5-fluorouracil or adriamycin in GC.
Conclusions:
These data demonstrate for the first time that examinations of hTERT mRNA expression as an important factor could be used to select the chemotherapeutic drugs for GC patients.
Virtual Slides:
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1793217009875483.
Insights
Telomerase reverse transcriptase (hTERT) mRNA expression in gastric cancer (GC) correlates with drug resistance. hTERT mRNA levels can help select sensitive chemotherapy drugs for GC patients, improving adjuvant therapy outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Determining sensitive chemotherapy drugs for gastric cancer (GC) is a major challenge in adjuvant therapy.
- Evaluating chemosensitivity and human telomerase reverse transcriptase (hTERT) mRNA expression in GC is crucial.
- Investigating the relationship between chemosensitivity and hTERT mRNA expression is key for personalized treatment.
Purpose of the Study:
- To evaluate the chemosensitivity of gastric cancer (GC) cells to various anticancer drugs.
- To examine the expression levels of human telomerase reverse transcriptase (hTERT) mRNA in GC tissues.
- To determine the correlation between hTERT mRNA expression and chemosensitivity in GC.
Main Methods:
- Primary culture of GC cells from 68 patients.
- MTT assay for chemosensitivity evaluation in 60 GC cases.
- In situ hybridization for hTERT mRNA expression in 60 GC tissues and adjacent normal mucosa.
Main Results:
- Taxol, cisplatin, and 5-fluorouracil showed higher efficacy than adriamycin and mitomycin for GC cells.
- Chemosensitivity was associated with tumor histological types and grade.
- Significantly increased hTERT mRNA expression in GC tissues correlated with poorer differentiation and resistance to 5-fluorouracil or adriamycin.
Conclusions:
- hTERT mRNA expression is significantly elevated in GC compared to normal tissues.
- hTERT mRNA expression is linked to worse differentiation and chemoresistance in GC.
- hTERT mRNA expression serves as a potential biomarker for selecting chemotherapeutic drugs in GC patients.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Replicative Cell Senescence
Cancer
